IQVIA has created a common Lexicon for the life sciences industry which enables the development of universal connectors for information exchanges across a network of internal and third-party external applications, IQVIA LEXI. IQVIA LEXI is embedded as part of IQVIA Technology Solutions' core architecture, enabling seamless connectivity between applications, including 3rd solutions, via less complex and more cost-effective integration technologies. By leveraging MuleSoftTM technology, IQVIA LEXI brings forward a connectivity capability unsurpassed in the life science industry.
LEXI enables immersive experiences across disparate business process flows, from molecule to market. IQVIA LEXI provides seamless connectivity to the IQVIA Technologies ecosystem and modernizes the interconnectivity of third-party applications with IQVIA Technologies’ solutions, improving speed to enterprise integration while streamlining maintenance effort while reducing expense.
The existing point-to-point integration model used by many life sciences companies is very complex and difficult to manage, especially in an ever-growing application landscape. By implementing IQVIA LEXI universal connectors, each system only needs integration via IQVIA LEXI into the IQVIA language to ensure access. IQVIA LEXI serves as an integration hub that gathers data from a single, or many systems translates the data to a standardized format and provides the data, securely, to each application across the ecosystem. LEXI integration significantly reducing the amount, the demand, and the expense of all the resources associated with integration.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes.
Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology, and extensive domain expertise, as well as execution capabilities. With approximately 67,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.